This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
CD30+ T-cell lymphoproliferative disorders
Chin Clin Oncol. 2019 Feb;8(1) :4
PMID: 30525751 URL: https://www.ncbi.nlm.nih.gov/pubmed/30525751
AbstractThe term "CD30+ T-cell lymphoproliferative disorders" describes a group of diverse diseases of the skin, subcutaneous tissues and mucosa that range from lesions requiring clinical observation to those necessitating systemic cytotoxic chemotherapy. Careful consideration of both clinical and histopathologic presentation is needed for appropriate diagnosis and treatment. This review will present the current classification of these disorders and potential treatment paradigms. Primary cutaneous CD30+ T-cell lymphoproliferative disorders, breast-implant associated anaplastic large-cell lymphoma and mucosal entities will be discussed.
Notes2304-3873 Martin, James M Wu, Hong Barta, Stefan K Review China Chin Clin Oncol. 2019 Feb;8(1):4. doi: 10.21037/cco.2018.09.06. Epub 2018 Oct 11